Pain Management
Chronic Pain
- Differential - Common conditions: Headache/migraine, back pain, osteoarthritis, fibromyalgia 
- Consider: Neuropathic pain, malignancy, infection 
 
- Adjuvant treatment (information for patients) - Lifestyle modification: Hydration, nutrition, sleep hygiene, low-impact exercise, yoga, smoking cessation 
- Massage, physical therapy, occupational therapy 
- Cognitive behavior therapy 
- Complementary and alternative medicine (e.g. acupuncture) 
 
Opioids
- Safe prescribing - Opioids and organ failure - Fentanyl is most appropriate for patients with ESRD 
- Methadone should not be used in patients with liver failure 
 
- Opioids for chronic pain - Avoid in general and only start for pain refractory to all reasonable non-opioid analgesic strategies 
- Starting therapy: Continue all non-opioid analgesic therapies, set reasonable treatment goals, and sign pain contract 
- If possible, limit dosing to ≤ 50 oral morphine equivalents per day 
- Prescribe naloxone intranasal 4 mg PRN respiratory depression 
- See patient every month during the first year and perform urine drug screening at each visit 
- After 1 year, see patient every 3 months and perform random urine drug screening at 50% of visits (e.g. per coin-flip) 
 
- Example regimens - Tramadol 50 mg (OME conversion factor = 0.1): 50 mg q8h = 15 OME/day 
- Hydrocodone-acetaminophen 5-325 mg (Norco, Vicodin): 1 tablet q6h = 20 OME/day 
- Oxycodone-acetaminophen 5-325 mg (Percocet): 1 tablet q6h = 30 OME/day 
 
 
- Decreasing or discontinuing opioids - Reasons - Patient centered: No significant analgesia despite dose increases, lack of functional improvement, dependency or adverse effects impacting quality of life 
- Health risks (e.g. sleep apnea, chronic pulmonary disease, prolonged QT interval) 
- Dangerous co-prescribing (e.g. benzodiazepines, muscle relaxants, other sedatives) 
- Prescribing > 90 oral morphine equivalents per day 
 
- Tapering process - BRAVO framework: Broaching the subject, risk-benefit calculation, addiction, velocity and validation, other strategies 
- Decrease original dose by 10% every 2 weeks while maintaining original dosing schedule as long as possible 
- Advise patients that body pain will worsen with each dose decrease and then return to baseline 
- Add adjuvant pain control (see chart above) and nonpharmacologic methods (see above) 
 
- Withdrawal symptom treatment - Diarrhea: Loperamide 4 mg q6h PRN for diarrhea 
- Pain/myalgia: Naproxen 500 mg q12h, acetaminophen 650 mg q4h PRN 
- Depression/irritability: Trazodone 50 mg at bedtime, MDD 150 mg (may not improve insomnia) 
- Anxiety: Hydroxyzine 25 mg q8h PRN 
 
 
